SCZM(SCZM)
SCZM
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $508M | $527M |
| Low | $486M | $504M |
| High | $530M | $550M |
| EBITDA Avg | $123M | $128M |
| Low | $118M | $123M |
| High | $129M | $134M |
| EBIT Avg | $84M | $87M |
| Low | $80M | $83M |
| High | $87M | $90M |
| Net Income Avg | $102M | $129M |
| Low | $96M | $121M |
| High | $108M | $136M |
| EPS Avg | $1.10 | $1.40 |
| Low | $1.04 | $1.32 |
| High | $1.17 | $1.47 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $124M | $131M |
| Low | $115M | $122M |
| High | $132M | $140M |
| EBITDA Avg | $30M | $32M |
| Low | $28M | $30M |
| High | $32M | $34M |
| EBIT Avg | $20M | $22M |
| Low | $19M | $20M |
| High | $22M | $23M |
| Net Income Avg | $24M | $27M |
| Low | $22M | $24M |
| High | $27M | $29M |
| EPS Avg | $0.26 | $0.28 |
| Low | $0.24 | $0.26 |
| High | $0.28 | $0.31 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |